Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study.

Jacqueline M Ratter-RieckMengya ShiKarsten SuhreCornelia PrehnJerzy AdamskiWolfgang RathmannBarbara ThorandMichael RodenAnnette PetersRui Wang-SattlerChristian Herder

Published in: BMJ open diabetes research & care (2024)

Our results suggest that omentin may influence insulin sensitivity and diabetes risk by changing systemic lipid metabolism, but further mechanistic studies investigating effects of omentin on metabolism of insulin-sensitive tissues are needed.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
gene expression
adipose tissue
fatty acid
case control
drug induced